Welcome to
Texas Biologics

Investing in disease prevention and treatment

Learn more about us

Photo credit: NEXU

Akaash Mishra in the lab


Through our innovative programs, Texas Biologics is investing in every phase of biologic development, from research support to clinical evaluation to commercialization.

Learn More

Current Projects

UT researchers are active in the development of new biologic therapies, including enzymes, antibodies, peptides and vaccines.

Learn More

Partner With Us

There are many ways to engage with Texas Biologics, from academic collaboration to technology licensing to philanthropic support.

Learn More

Pilot Grant Awardees

A major goal of Texas Biologics is to strengthen and expand biomedical translational research at UT by providing financial support for projects in biologics discovery and development. We launched the TXBio Pilot Grant Program this year to foster research across campus.

Read more about the 2022 awardees


Patents since 2012


Raised via spinoff companies


Drugs in commercial use or development


illustration of antibody attacking metapneumovirus
September 22, 2022

New research could pave the way for a vaccine for a common respiratory virus.

Read more
illustration of transmembrane stem cell factor
June 08, 2022

Several years ago, a promising therapeutic using stem cell factor (SCF) emerged that could potentially treat a variety of ailments, such as ischemia, heart attack, stroke and radiation exposure. However, during clinical trials, numerous patients suffered severe allergic reactions and development of SCF-based therapeutics stopped. A research team led by engineers at The University of Texas at Austin has developed a related therapeutic that they say avoids these major allergic reactions while maintaining its therapeutic activity.

Read more
Jason McClellan standing in lab
June 01, 2022

University of Texas at Austin molecular biosciences professor Jason McLellan was selected as a finalist for the 2022 Blavatnik National Awards for Young Scientists.

Read more